SEC Form 4 · accession 0001209191-17-010046
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
MD Pascal J Goldschmidt
Director
Period of report
Feb 10, 2017
Accepted (ET)
Feb 13, 2017 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 10, 2017 | M | 818 | $32.325 | A | 14,173 | D | |
| Common Stock | Feb 10, 2017 | M | 10,668 | $27.715 | A | 24,841 | D | |
| Common Stock | Feb 10, 2017 | M | 9,922 | $29.355 | A | 34,763 | D | |
| Common Stock | Feb 10, 2017 | M | 8,280 | $36.25 | A | 43,043 | D | |
| Common StockF1 | Feb 10, 2017 | S | 25,294 | $67.8152 | D | 17,749 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $32.325 | Feb 10, 2017 | M | 818 | D | Nov 1, 2010 | Nov 1, 2017 | Common Stock | 818 | 0 | D |
| Stock Options (Right to Buy) | $27.715 | Feb 10, 2017 | M | 10,668 | D | May 23, 2011 | May 23, 2018 | Common Stock | 10,668 | 0 | D |
| Stock Options (Right to Buy) | $29.355 | Feb 10, 2017 | M | 9,922 | D | May 6, 2013 | May 6, 2020 | Common Stock | 9,922 | 0 | D |
| Stock Options (Right to Buy) | $36.25 | Feb 10, 2017 | M | 8,280 | D | May 5, 2014 | May 5, 2021 | Common Stock | 8,280 | 0 | D |
Explanation of responses
- F1Sales of shares were made in thirty-three (33) separate transactions with prices ranging from $67.70 to $68.05 for an average weighted sales price of $67.8152.